Glycemic index of Pentasure DM and Pentasure 2.0
- Registration Number
- CTRI/2023/04/051715
- Lead Sponsor
- Madras Diabetes Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age 18 to 45 years
BMI greater than equal to 18.5 to less than equal to 22.9 kg/ m2 (as per WHO cut off for normal BMI)
Both male and female
Willingness to consume the test foods
no known food allergy or intolerance;
no medications known to affect glucose tolerance (excluding oral contraceptives) â?? stable doses of oral contraceptives, acetylsalicylicacid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.
a known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions
pregnant or lactating women
a major medical or surgical event requiring hospitalization within the preceding 3 months;
the presence of disease or drug(s) which influence digestion and absorption of nutrients;
the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycemic index, Glycemic Response and GI category of food products.Timepoint: Glycemic index testing of all foods will be done on separate days. For both intervention and comparator agents capillary blood samples will be collected at -5,0 (fasting state) and at 15,30,45,60,90,120 mins from the first sip of test and reference foods. The glycemic index of test foods will be determined based on the capillary blood glucose values collected
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI